AI Drug Discovery's Validation Gap Is the Story Capital Is Ignoring
Record capital is flooding AI drug discovery while the field's core bottleneck — validating generated molecules faster than they are produced — goes unaddressed.
Record capital is flooding AI drug discovery while the field's core bottleneck — validating generated molecules faster than they are produced — goes unaddressed.
You've read 10 of 10 free stories this month. Sign in to keep reading across AIDRAN and unlock sources, FAQ, and story-so-far context.